» Articles » PMID: 11344033

Matrix Metalloproteinases in Cancer Invasion, Metastasis and Angiogenesis

Overview
Specialty Pharmacology
Date 2001 May 10
PMID 11344033
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Matrix metalloproteinases (MMPs) are a family of proteinases that play an important role in cancer as well as in numerous other diseases. In this article, we summarize the current views on the role of MMPs in cancer with respect to invasion, metastasis and angiogenesis. A positive correlation between tumor progression and the expression of multiple MMP family members in tumor tissues has been demonstrated in numerous human and animal studies. It has been assumed that cancer cells are responsible for producing the MMPs in human tumors. However, recent evidence suggests that tumor cells have docking sites that bind stromal-cell-secreted MMPs. Furthermore, the role of MMPs produced by endothelial cells, especially MMP-2 and MT1-MMP, appear to be crucial for tumor angiogenesis, which is a requirement for cancer growth and dissemination.

Citing Articles

Rational strategies for designing next-generation oncolytic viruses based on transcriptome analysis of tumor cells infected with oncolytic herpes simplex virus-1.

Javid N, Abdoli S, Shahbazi M Front Oncol. 2025; 14():1469511.

PMID: 39850819 PMC: 11754274. DOI: 10.3389/fonc.2024.1469511.


Mechanistic insights into 's anti-proliferative and pro-apoptotic effects in A549 lung cancer cells: targeting PI3K/Akt pathway and ROS production.

Alshehri M, Seyed M, Panneerselvam C, Sayed S, Shukry M Toxicol Res (Camb). 2024; 13(5):tfae137.

PMID: 39233844 PMC: 11368664. DOI: 10.1093/toxres/tfae137.


Tivozanib-induced activation of the mitochondrial apoptotic pathway and suppression of epithelial-to-mesenchymal transition in oral squamous cell carcinoma.

Choi N, Park S, Kim I Korean J Physiol Pharmacol. 2024; 28(3):197-207.

PMID: 38682168 PMC: 11058548. DOI: 10.4196/kjpp.2024.28.3.197.


Downregulated BIRC5 inhibits proliferation and metastasis of melanoma through the β-catenin/HIF-1α/VEGF/MMPs pathway.

He Q, He Y, Li C, Wang J, Xia T, Xiong X J Cancer Res Clin Oncol. 2023; 149(18):16797-16809.

PMID: 37728702 DOI: 10.1007/s00432-023-05425-3.


Suppression of TLR signaling by IRAK-1 and -4 dual inhibitor decreases TPF-resistance-induced pro-oncogenic effects in HNSCC.

Khan H, Pandey S, Mishra A, Srivastava R 3 Biotech. 2022; 13(1):14.

PMID: 36540413 PMC: 9759608. DOI: 10.1007/s13205-022-03420-y.